1 Post-Genomics and the Future of Human Societies: a Foresight Approach Excerpts from “ DNA Analysis for Human Health in the Post- Genomic Era - An APEC-wide.

Slides:



Advertisements
Similar presentations
OECD International Futures Programme 1 OECD Futures Project The Commercialisation of Space and the Development of Space Infrastructure: The Role of Public.
Advertisements

PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Trade and Health National Assessment The World Health Organisations Diagnostic Tool on Trade and Health Presented by: Corinna Hawkes, Consultant
Excellence with Impact Declan Mulkeen January 2011.
Computing Research in Latin America Jaime Puente Program Manager External Research & Programs Microsoft Research Jaime Puente Program Manager External.
Organización Panamericana de la Salud.... Information Knowledge Management Evolution of Bioethics Dr. Richard Van West-Charles.
NIS in Poland current situation and recommendations for the future I. Kijenska Faculty of Materials Science and Engineering, Warsaw University of Technology/PRESAFE.
“Steering and Funding – The Governance of science systems” Sources Based ont the reports of the Ad Hoc Working Group Steering and Funding of Research Institutions.
10 th October 2013 The delivery of 21 st century services – the implications for the evolution of the Healthcare Science workforce Joan Fletcher.
APEC Regulatory Harmonization Steering Committee (RHSC) Institute of Medicine Workshop International Regulatory Harmonization Amid Globalization of Biomedical.
Recap Day 2. Key messages Day 1 Why CPEIRs? How they were done in different countries? Findings and recommendations Day 2 Questions and themes emerging.
Analysing university-firm interaction in the SADC countries: An initial overview Glenda Kruss SARUA workshop October 2008.
Resource Allocation in Translational Neuroscience: An Industry Perspective in 2009 Janet Vergis President Janssen, McNeil Pediatrics, and Ortho-McNeil.
The Impact of the Human Genome Project on Public Health Practice
FOODIMA Food Industry Dynamics and Methodological Advances Contract No Priority 8.1 B1.1 Sustainable Management of Europe’s Natural Resources 5th.
Challenge of personalized health care: To what extent is medicine already individualized and what are the future trends? Author: Walter Fierz Presented.
The National Academies’ Board on Life Sciences Dr. Frances Sharples Director National Research Council National Research Council.
Overview Summary from Africa and ASEAN assistance Dr. Peter Pembleton, UNIDO.
A Survey of Scientific and Technology Policy of The Republic of Croatia until 2010 Beograd November 30, 2007 Dr. sc. Milan Ivanović Faculty of Electrical.
J. Karadzinska-Bislimovska, S.Risteska-Kuc Institute of Occupational Health -WHO Collaborating Center for Occupational Health,Skopje National health policy.
3rd Baltic Conference on Medicines Economic Evaluation, Reimbursement and Rational Use of Pharmaceuticals Pricing and Reimbursement of Pharmaceuticals.
Asia Pacific Economic Cooperation Workshop on Meteorological and Hydrologic Cooperation Within APEC January 12, 2001 Albuquerque, NM.
Overview: 21st Century Competencies and Skills Policy Analysis Maria Laura Munoz Villanueva Ministry of Education Peru.
9/30/2004TCSS588A Isabelle Bichindaritz1 Introduction to Bioinformatics.
Outcomes of Public Health
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
HSP progress in Taiwan 2009 Benjamin I. Kuo, MD, DrPH, CIP Secretariat, Joint Institutional Review Board.
Presidency of Council of Ministers National Committee for Biosafety, Biotechnology and Life Sciences (D.P.C.M. March 19, 2007)
Horizon 2020 The EU Framework Programme for Research and Innovation Health, Demographic Change and Wellbeing Lul Raka, NCP for Horizon 2020 – Health.
NICE Decision Making Dr Katherine Payne North West Genetics Knowledge Park The University of Manchester
Genetic advances will only be acceptable if their application is carried out ethically, with due regard to autonomy, justice, education and the beliefs.
INTRODUCTION TO RA.
Pharmacogenomics. Developing drugs on the basis of individual genetic differences Tailoring therapies to genetically similar subpopulations results in.
Japan’s FTAs/EPAs with APEC Economies Nobuhiko Sasaki Deputy Director-General APEC Senior Official METI Japan March 2006.
Expert Input : Review of Days 1 & 2 1. Forum Days 1 & 2 2 Overview of Days’ 1 & 2 Themes, Sessions, and Guiding Questions.
Overview Science, Technology, Enterprise and Innovation Social issues related to Science and Technology (S&T) Communication of high.
Thirty Eight APEC Transportation Working Group Meeting, Bali, Indonesia 1 – 5 July 2013 Thirty Eight APEC Transportation Working Group Meeting, Bali, Indonesia.
Sciences, Ethics & Thai Society Sciences Ethics & Thai Society Whose Ethics? Tax evasion of top politicians = all businessmen did it An engineer.
2015 A PPLICATION P ROCESS FOR APEC-F UNDED P ROJECTS Chen-Sheng Ho, Ph.D. Associate Research Fellow Chinese Taipei APEC Study Center Taiwan Institute.
Informing a data revolution right data, to the right people, at the right time, in the right format The IDR road map Bangkok Regional Workshop July 17-18,2014.
Future Technology Analysis for Biosecurity and Emerging Infectious Diseases in Asia-Pacific Nares Damrongchai, Ponpiboon Satangput, Greg Tegart, and Chatri.
Global Recognition of the Indian Biotech Sector - The Road Ahead Sept 26,2003 Hyderabad.
Regulation and the Governance Agenda in the 21 st Century Josef Konvitz, Public Governance Directorate.
Measuring Inbound Diffusion from Publicly Funded Research Organizations to Innovative Firms: A Statistical Perspective Frances Anderson Science, Innovation.
A U.S. Department of Energy Office of Science Laboratory Operated by The University of Chicago Argonne National Laboratory Office of Science U.S. Department.
A U.S. Department of Energy Office of Science Laboratory Operated by The University of Chicago Argonne National Laboratory Office of Science U.S. Department.
D.Zucker Draft-EB09 Ethics & Academic Technology Transfer: Patients, Products and Public Trust Deborah Zucker, MD, PhD, Tufts Medical Center.
Pharmacogenomics in Japan Hiroshi Gushima Director R&D Planning & Administration Department Yamanouchi Pharmaceutical Co., Ltd. From reports, “Pharmacogenomics”
Research Services Research Services Presentation to Department of Paediatrics Gill Rowe Head, Research Services, Medical Sciences 23 September 2015.
SOCIAL BUSINESS PLAN. SOCIAL BUSINESS  Social enterprise is a business that trades for a social purpose. The social aims of the business are of equal.
Identifying the Impacts of Technology Transfer Beyond Commercialization FPTT National Meeting, June 12, 2007.
 2002 T 1 Second Annual Medical Research Summit The Context of Clinical Research: Challenges and Opportunities March 25, 2002 Washington, DC Leslie A.
Pharmacists Perceptions of the Development of Herbal Medicines in Iran
The ELSI Implications of Gene Therapy under the UNESCO Declaration -a Taiwan’s Perspective Panelist : Lin, Jui-Chu & Wang, Triumph.
Defining the Research Ethics Research ethics involves the application of fundamental ethical principles to a variety of topics involving research, including.
WHO Medicines Strategy Progress: Priorities: Dr Guitelle Baghdadi Essential Drugs and Medicines Policy World Health Organization November.
A U.S. Department of Energy Office of Science Laboratory Operated by The University of Chicago Argonne National Laboratory Office of Science U.S. Department.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
I farmaci innovativi in una prospettiva europea Giuseppe M.C. Rosano, MD, PhD Cardiovascular and Cell Sciences Research Institute, St George's University.
A Crucial Moment for Scientific Cooperation ESOF-2014 June 25, 2014.
Energy Regulation: Roles and Responsibilities
NATIONAL e-STRATEGY Presentation to the Portfolio Committee on Telecommunications & Postal Services DG: ROBERT NKUNA AUGUST 2017 Building a better life.
Innovation Development Strategy
Dr. Nares Damrongchai Policy Researcher
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Translational Research: Case of Istanbul University
Reflections on International Cooperation
National Cancer Center
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Overview of Good Regulatory Practice
Presentation transcript:

1 Post-Genomics and the Future of Human Societies: a Foresight Approach Excerpts from “ DNA Analysis for Human Health in the Post- Genomic Era - An APEC-wide Technology Foresight Study Dr. Nares Damrongchai Policy Researcher APEC Center for Technology Foresight National Science and Technology Development Agency, Thailand 24 January 2004 Bangkok, Thailand

2 Background April 2003, Human Genome Project officially declared complete.  But... Reaping the rewards and reducing the dangers of technological advances demands careful consideration of 2 dimensions. First, how various socio-economic environments lead to differences in the pace and direction of technological innovation and diffusion, and second, what the implications are of the uses and spread of new technologies for economy and society OECD st Century Technologies

3 Integration of Post-Genomics into the Society Adapted from David W. Beier, Life Sciences Innovation Value Chain, Post- Genomics Research Health- care System Development of Products and Services Translation Intellectual property protection Capital markets Transparency International standards Legal and regulatory infrastructure ensures benefit to individuals and society PUBLIC POLICY PRIVATE SECTOR Development of new technologies Basic research at public and private academic institutions Education and training Clinical trial Manufacturing and marketing or distribution of products and services Insurers Pharmacies Hospitals Medical professionals Human populations and societies

4 APEC-wide Foresight Study on “ DNA Analysis for Human Health in the Post-Genomic Era ” Proposing Economy: Thailand Co-sponsors: Canada; Japan; Philippines; Chinese Taipei and USA Period: mid 2002 to 2003

5 Project Roadmap 2002 NOV 2003 APR MAY AUG 2004 JAN Overview Paper Foresight Support And Organi- zation Post- Foresight Position Papers Issues Papers APEC-wide Meeting in Bangkok Preliminary findings APEC Ministerial Meeting, mid OCT Core Group Meeting 3-4 APR, BKK Web-based National Surveys ISTWG Meeting Final Report, DEC 2003

6 Technological Developments and New Research Approaches in “Post- Genomics” Era SNPs Analysis Microarray Bioinformatics Proteomics Pharmacogenomics Rational Drug Design Gene Therapy Population Genomics and Linkage Studies Genetic Profiling

7 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region The success and failure of scientific and technology promises. This also includes the speed and cost involved in the development and application of the technology.

8 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region Social influence. Each society may have similar or different attitudes based on social, ethnic, religion backgrounds as well as the interpretation of human right and human dignity issues. This depends on the structure and mechanism to educate the public, the open discussion and the mobilization of public attitudes.

9 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region The effects or perception of impacts of genomics to societies and the environment. This is a combination of the benefit, risk, adverse effect, past-experience of the societies, cost and accessibility.

10 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region Regulation of genomic research and their applications. These regulations can be based on safety, economic, or ethical reasons. For example, embryonic stem cells are regulated on the research end, and cloning on the application end.

11 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region The demand of the genomics-related health products. This is related to the success and the varieties of products (risk screening, diagnostics, intervention or therapeutic tools as the results of genomic research). CC:

12 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region The genomics related business involvement. This include public policy to promote investment in genomics and the different business environment in each economy.

13 CRITICAL FACTORS that influence the development and impact of genomics for human health in APEC region Intellectual property management. In terms of protection of innovation and development as well as the accessibility and distribution of knowledge.

14 “Uncertainties” A clear enough future A B C Alternate futures A range of futures ? True ambiguity

15 “Scenarios” prosperity crisis trends Scenario 1 Scenario 2Scenario 3 strategy

16 “ Scenario building ” “ Presenting the draft ”

“ We discovere d the secret of life"